GENEVA, July 6 -- SHANGHAI MEIYUE BIOTECH DEVELOPMENT CO., LTD. filed a patent application (CN2025/145071) for “USE OF MOLECULAR GLUE COMPOUND IN PREPARING MEDICAMENT FOR PREVENTING AND/OR TREATING IGA NEPHROPATHY”. With publication no. WO/2026/138862, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/4545
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....